Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Liver Cell Infusion (Heparesc) in Children With Urea Cycle Disorders
NCT01195753Phase 2Terminated
- Sponsor
- Cytonet
- Start
- Dec 2010
- Primary completion
- Dec 2015
- Modality
- Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of Heparesc in urea cycle disorders (UCD), sponsored by Cytonet. Started Dec 2010; status: terminated.
02
Drugs
Heparesc
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT01195753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195753.